title: [Prognosis of intra-arterial chemo-embolization in metastatic liver cancer].
abstract: We treated 63 patients (pts) suffering from metastatic liver cancer with intra-arterial infusion chemotherapy, and analysed 44 of their for survival since the first treatment with regard to the primary foci of cancer and the method of intra-arterial therapy. Via the superficial femoral artery, we performed superselective hepatic catheterization by Seldinger's method. Three types of intraarterial therapy were used: Gelfoam embolization with mitomycin-C (MMC) in 12 pts (GS-TAE), capillary chemo-embolization with MMC-Lipiodol emulsion in 28 pts (LP-TAI) and "one-shot" slow infusion of MMC or cisplatinum in 4 pts. Fifty-percent survival was 189 days in pts with metastases from colo-rectal cancer (n = 20), 109 days from gastric cancer (n = 9), 100 days from pancreatobiliary cancer (n = 5) and 240 days from breast cancer (n = 7). More than one-year survival was obtained in 13 out of the 40 pts (32.5%). Survival of 12 pts, treated with GS-TAE regimen, was not significantly superior to that of 28 pts with LP-TAI regimen. Hence, we conclude that LP-TAI is the treatment of choice in chemo-embolization for unresectable liver metastases, because it causes less damage to the hepatic arterial beds, and facilitates repeat intraarterial therapy in these pts.
authors.affiliation: Dept. of Gastroenterology, Shizuoka General Hospital.
authors.forename: K
authors.initials: K
authors.lastname: Ito
authors.forename: F
authors.initials: F
authors.lastname: Hattori
authors.forename: A
authors.initials: A
authors.lastname: Takagi
authors.forename: M
authors.initials: M
authors.lastname: Kida
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
authors.forename: H
authors.initials: H
authors.lastname: Matsumoto
authors.forename: K
authors.initials: K
authors.lastname: Kojima
authors.forename: J
authors.initials: J
authors.lastname: Iseki
authors.forename: K
authors.initials: K
authors.lastname: Toyama
authors.forename: N
authors.initials: N
authors.lastname: Nakajima
mesh_terms: D002945:Cisplatin / Q000008:administration & dosage; D004621:Embolization, Therapeutic / Q000379:methods; D004655:Emulsions; D005781:Gelatin Sponge, Absorbable; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D007459:Iodized Oil / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage* / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D004655:Emulsions; D008937:Mitomycins; D016685:Mitomycin; D007459:Iodized Oil; D002945:Cisplatin